福安药业：子公司腺苷钴胺胶囊获药品注册证书

Core Viewpoint - Fu'an Pharmaceutical's subsidiary Tianheng Pharmaceutical has received a drug registration certificate from the National Medical Products Administration for Adenosylcobalamin Capsules, enhancing its product line and market competitiveness [1] Company Summary - The drug is classified as a Class 3 chemical drug with a specification of 0.5mg [1] - The drug is indicated for the treatment of megaloblastic anemia and has passed consistency evaluations by several other companies [1] - The approval number for the drug is Guoyao Zhunzi H20254594, and Tianheng Pharmaceutical is the marketing authorization holder [1] Industry Summary - The registration of this drug will enrich the product portfolio of the subsidiary, potentially increasing its competitive edge in the pharmaceutical market [1]